$2.96
-0.08[-2.63%]
At close: Apr 18
$2.96
0[0.00%]
PreMarket: 8:26AM EDT
Cyclerion Therapeutics
(NASDAQ:CYCN)Cyclerion Therapeutics Stock (NASDAQ:CYCN), Analyst Ratings, Price Targets, Predictions
Cyclerion Therapeutics Inc has a consensus price target of $10.5, established from looking at the 2 latest analyst ratings. The last 2 analyst ratings were released from Truist Securities and Cantor Fitzgerald on October 20, 2021 and September 24, 2021. With an average price target of $10.5 between Truist Securities and Cantor Fitzgerald, there's an implied 254.73% upside for Cyclerion Therapeutics Inc from these 2 analyst ratings.
Analyst Firms Making Recommendations1
Truist Securities
Cantor Fitzgerald
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Cyclerion Therapeutics
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10/20/2021 | CYCN | Buy Now | Cyclerion Therapeutics | $2.96 | 372.97% | Truist Securities | — | — | Initiates | → Buy | Get Alert |
| 09/24/2021 | CYCN | Buy Now | Cyclerion Therapeutics | $2.96 | 136.49% | Cantor Fitzgerald | — | — | Initiates | → Overweight | Get Alert |
FAQ
What is the target price for Cyclerion Therapeutics (CYCN)?
The latest price target for Cyclerion Therapeutics (NASDAQ: CYCN) was reported by Truist Securities on October 20, 2021. The analyst firm set a price target for $14.00 expecting CYCN to rise to within 12 months (a possible 372.97% upside). 0 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Cyclerion Therapeutics (CYCN)?
The latest analyst rating for Cyclerion Therapeutics (NASDAQ: CYCN) was provided by Truist Securities, and Cyclerion Therapeutics initiated their buy rating.
When was the last upgrade for Cyclerion Therapeutics (CYCN)?
There is no last upgrade for Cyclerion Therapeutics.
When was the last downgrade for Cyclerion Therapeutics (CYCN)?
There is no last downgrade for Cyclerion Therapeutics.
When is the next analyst rating going to be posted or updated for Cyclerion Therapeutics (CYCN)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Cyclerion Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Cyclerion Therapeutics was filed on October 20, 2021 so you should expect the next rating to be made available sometime around October 20, 2022.
Is the Analyst Rating Cyclerion Therapeutics (CYCN) correct?
While ratings are subjective and will change, the latest Cyclerion Therapeutics (CYCN) rating was a initiated with a price target of $0.00 to $14.00. The current price Cyclerion Therapeutics (CYCN) is trading at is $2.96, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.